BioAtla
BCAB
91 hedge funds and large institutions have $279M invested in BioAtla in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 11 closing their positions.
164% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 11
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
95% more call options, than puts
Call options by funds: $1.22M | Put options by funds: $625K
94% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 16
34% more capital invested
Capital invested by funds: $208M → $279M (+$70.6M)
25% more funds holding
Funds holding: 73 → 91 (+18)
0.02% less ownership
Funds ownership: 1.49% → 1.47% (-0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.5M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$12.4M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$10.5M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.6M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$19.6M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$6.62M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.12M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$4.43M |
| 5 |
ACM
Altium Capital Management
New York
|
-$4.26M |
BCAB Hedge Fund Activity: Q4 2022 in Review
91 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q4 2022, worth a combined $279M — up 34% from $208M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BCAB positions and 11 closed out — a net gain of 18 holders — while 31 added to existing stakes and 16 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $14.5M. The largest seller was Janus Henderson Group, cutting an estimated $19.6M.
- 91 institutional investors held BioAtla (BCAB) as of Q4 2022, up from 73 in Q3 2022.
- Funds reported $279M of BioAtla stock for Q4 2022, up 34% quarter-over-quarter.
- 29 funds opened new BioAtla positions in Q4 2022 and 11 closed out, a net change of +18 holders.
- The largest BioAtla buyer in Q4 2022 was Adage Capital Partners, an estimated $14.5M added.
- The largest BioAtla seller in Q4 2022 was Janus Henderson Group, an estimated $19.6M sold.
Based on aggregated 13F filings for Q4 2022.